Pfizer Inc., launched a new initiative called ‘An Accord for a Healthier World’. This initiative aims to provide all the patented, high-quality medicines, and vaccines of Pfizer available in the United States and European Union on a not-for-profit basis to 1.2 billion people in 45 lower-income countries.
This initiative seeks to greatly decrease the health inequalities that exist between many low-income countries and the rest of the world. Albert Bourla, chairman and chief executive officer of Pfizer, said in the global launch of COVID-19 vaccine and supply, they learned that it is just a first step to help patients. They will work closely with the global health leaders to make changes in education, diagnosis, storage, infrastructure, and more.
The Accord countries include all the 27 low-income countries as well as 18 low and middle-income countries that have transitioned from the low to middle-income classification in the past ten years.
Pfizer will work with the health officials based in Ghana, Malawi, Rwanda, Senegal, and Uganda to identify early insights, and opportunities to ensure all vaccines and medicines reach people who are in need. This initiative also includes expertise to support diagnosis, healthcare professional education, and training, along with supply chain management, and several other infrastructure enhancements.
